0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Tubeless Wearable Insulin Pump Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-16Q16942
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global Tubeless Wearable Insulin Pump Market Research Report 2024
BUY CHAPTERS

Global Tubeless Wearable Insulin Pump Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-16Q16942
Report
November 2025
Pages:142
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Tubeless Wearable Insulin Pump Market

The global Tubeless Wearable Insulin Pump market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Insulin pumps can help people with diabetes conveniently manage their blood sugar. Tubeless wearable insulin pump (patch pumps) is an insulin pump that has no tube and is worn on the skin.
From a downstream perspective, Type 1 Diabetes accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Tubeless Wearable Insulin Pump leading manufacturers including Insulet Corporation, Roche, EOFlow, PharmaSens, CeQur, Debiotech, Valeritas, Terumo, MicroTech Medical, Medtrum Technologies, etc., dominate supply; the top five capture approximately % of global revenue, with Insulet Corporation leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Tubeless Wearable Insulin Pump market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Tubeless Wearable Insulin Pump Market Report

Report Metric Details
Report Name Tubeless Wearable Insulin Pump Market
Segment by Type
  • All-throwable
  • Semi-throwable
Segment by Application
  • Type 1 Diabetes
  • Type 2 Diabetes
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Insulet Corporation, Roche, EOFlow, PharmaSens, CeQur, Debiotech, Valeritas, Terumo, MicroTech Medical, Medtrum Technologies
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Tubeless Wearable Insulin Pump study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Tubeless Wearable Insulin Pump Market report?

Ans: The main players in the Tubeless Wearable Insulin Pump Market are Insulet Corporation, Roche, EOFlow, PharmaSens, CeQur, Debiotech, Valeritas, Terumo, MicroTech Medical, Medtrum Technologies

What are the Application segmentation covered in the Tubeless Wearable Insulin Pump Market report?

Ans: The Applications covered in the Tubeless Wearable Insulin Pump Market report are Type 1 Diabetes, Type 2 Diabetes

What are the Type segmentation covered in the Tubeless Wearable Insulin Pump Market report?

Ans: The Types covered in the Tubeless Wearable Insulin Pump Market report are All-throwable, Semi-throwable

1 Study Coverage
1.1 Introduction to Tubeless Wearable Insulin Pump: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Tubeless Wearable Insulin Pump Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 All-throwable
1.2.3 Semi-throwable
1.3 Market Segmentation by Application
1.3.1 Global Tubeless Wearable Insulin Pump Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Type 1 Diabetes
1.3.3 Type 2 Diabetes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Tubeless Wearable Insulin Pump Revenue Estimates and Forecasts 2020-2031
2.2 Global Tubeless Wearable Insulin Pump Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Tubeless Wearable Insulin Pump Sales Estimates and Forecasts 2020-2031
2.4 Global Tubeless Wearable Insulin Pump Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Tubeless Wearable Insulin Pump Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Tubeless Wearable Insulin Pump Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 All-throwable Market Size by Manufacturers
3.5.2 Semi-throwable Market Size by Manufacturers
3.6 Global Tubeless Wearable Insulin Pump Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Tubeless Wearable Insulin Pump Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Tubeless Wearable Insulin Pump Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Tubeless Wearable Insulin Pump Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Tubeless Wearable Insulin Pump Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Tubeless Wearable Insulin Pump Sales and Revenue by Type (2020-2031)
6.4 North America Tubeless Wearable Insulin Pump Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Tubeless Wearable Insulin Pump Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Tubeless Wearable Insulin Pump Sales and Revenue by Type (2020-2031)
7.4 Europe Tubeless Wearable Insulin Pump Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Tubeless Wearable Insulin Pump Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Tubeless Wearable Insulin Pump Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Tubeless Wearable Insulin Pump Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Tubeless Wearable Insulin Pump Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Tubeless Wearable Insulin Pump Sales and Revenue by Type (2020-2031)
9.4 Central and South America Tubeless Wearable Insulin Pump Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Tubeless Wearable Insulin Pump Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Tubeless Wearable Insulin Pump Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Tubeless Wearable Insulin Pump Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Tubeless Wearable Insulin Pump Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Insulet Corporation
11.1.1 Insulet Corporation Corporation Information
11.1.2 Insulet Corporation Business Overview
11.1.3 Insulet Corporation Tubeless Wearable Insulin Pump Product Models, Descriptions and Specifications
11.1.4 Insulet Corporation Tubeless Wearable Insulin Pump Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Insulet Corporation Tubeless Wearable Insulin Pump Sales by Product in 2024
11.1.6 Insulet Corporation Tubeless Wearable Insulin Pump Sales by Application in 2024
11.1.7 Insulet Corporation Tubeless Wearable Insulin Pump Sales by Geographic Area in 2024
11.1.8 Insulet Corporation Tubeless Wearable Insulin Pump SWOT Analysis
11.1.9 Insulet Corporation Recent Developments
11.2 Roche
11.2.1 Roche Corporation Information
11.2.2 Roche Business Overview
11.2.3 Roche Tubeless Wearable Insulin Pump Product Models, Descriptions and Specifications
11.2.4 Roche Tubeless Wearable Insulin Pump Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Roche Tubeless Wearable Insulin Pump Sales by Product in 2024
11.2.6 Roche Tubeless Wearable Insulin Pump Sales by Application in 2024
11.2.7 Roche Tubeless Wearable Insulin Pump Sales by Geographic Area in 2024
11.2.8 Roche Tubeless Wearable Insulin Pump SWOT Analysis
11.2.9 Roche Recent Developments
11.3 EOFlow
11.3.1 EOFlow Corporation Information
11.3.2 EOFlow Business Overview
11.3.3 EOFlow Tubeless Wearable Insulin Pump Product Models, Descriptions and Specifications
11.3.4 EOFlow Tubeless Wearable Insulin Pump Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 EOFlow Tubeless Wearable Insulin Pump Sales by Product in 2024
11.3.6 EOFlow Tubeless Wearable Insulin Pump Sales by Application in 2024
11.3.7 EOFlow Tubeless Wearable Insulin Pump Sales by Geographic Area in 2024
11.3.8 EOFlow Tubeless Wearable Insulin Pump SWOT Analysis
11.3.9 EOFlow Recent Developments
11.4 PharmaSens
11.4.1 PharmaSens Corporation Information
11.4.2 PharmaSens Business Overview
11.4.3 PharmaSens Tubeless Wearable Insulin Pump Product Models, Descriptions and Specifications
11.4.4 PharmaSens Tubeless Wearable Insulin Pump Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 PharmaSens Tubeless Wearable Insulin Pump Sales by Product in 2024
11.4.6 PharmaSens Tubeless Wearable Insulin Pump Sales by Application in 2024
11.4.7 PharmaSens Tubeless Wearable Insulin Pump Sales by Geographic Area in 2024
11.4.8 PharmaSens Tubeless Wearable Insulin Pump SWOT Analysis
11.4.9 PharmaSens Recent Developments
11.5 CeQur
11.5.1 CeQur Corporation Information
11.5.2 CeQur Business Overview
11.5.3 CeQur Tubeless Wearable Insulin Pump Product Models, Descriptions and Specifications
11.5.4 CeQur Tubeless Wearable Insulin Pump Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 CeQur Tubeless Wearable Insulin Pump Sales by Product in 2024
11.5.6 CeQur Tubeless Wearable Insulin Pump Sales by Application in 2024
11.5.7 CeQur Tubeless Wearable Insulin Pump Sales by Geographic Area in 2024
11.5.8 CeQur Tubeless Wearable Insulin Pump SWOT Analysis
11.5.9 CeQur Recent Developments
11.6 Debiotech
11.6.1 Debiotech Corporation Information
11.6.2 Debiotech Business Overview
11.6.3 Debiotech Tubeless Wearable Insulin Pump Product Models, Descriptions and Specifications
11.6.4 Debiotech Tubeless Wearable Insulin Pump Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Debiotech Recent Developments
11.7 Valeritas
11.7.1 Valeritas Corporation Information
11.7.2 Valeritas Business Overview
11.7.3 Valeritas Tubeless Wearable Insulin Pump Product Models, Descriptions and Specifications
11.7.4 Valeritas Tubeless Wearable Insulin Pump Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Valeritas Recent Developments
11.8 Terumo
11.8.1 Terumo Corporation Information
11.8.2 Terumo Business Overview
11.8.3 Terumo Tubeless Wearable Insulin Pump Product Models, Descriptions and Specifications
11.8.4 Terumo Tubeless Wearable Insulin Pump Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Terumo Recent Developments
11.9 MicroTech Medical
11.9.1 MicroTech Medical Corporation Information
11.9.2 MicroTech Medical Business Overview
11.9.3 MicroTech Medical Tubeless Wearable Insulin Pump Product Models, Descriptions and Specifications
11.9.4 MicroTech Medical Tubeless Wearable Insulin Pump Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 MicroTech Medical Recent Developments
11.10 Medtrum Technologies
11.10.1 Medtrum Technologies Corporation Information
11.10.2 Medtrum Technologies Business Overview
11.10.3 Medtrum Technologies Tubeless Wearable Insulin Pump Product Models, Descriptions and Specifications
11.10.4 Medtrum Technologies Tubeless Wearable Insulin Pump Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Medtrum Technologies Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Tubeless Wearable Insulin Pump Industry Chain
12.2 Tubeless Wearable Insulin Pump Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Tubeless Wearable Insulin Pump Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Tubeless Wearable Insulin Pump Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Tubeless Wearable Insulin Pump Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Tubeless Wearable Insulin Pump Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global Tubeless Wearable Insulin Pump Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Tubeless Wearable Insulin Pump Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Tubeless Wearable Insulin Pump Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Tubeless Wearable Insulin Pump Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Tubeless Wearable Insulin Pump Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Tubeless Wearable Insulin Pump Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 7. Global Tubeless Wearable Insulin Pump Sales by Region (2020-2025) & (K Units)
 Table 8. Global Tubeless Wearable Insulin Pump Sales by Region (2026-2031) & (K Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Tubeless Wearable Insulin Pump Sales by Manufacturers (2020-2025) & (K Units)
 Table 11. Global Tubeless Wearable Insulin Pump Sales Share by Manufacturers (2020-2025)
 Table 12. Global Tubeless Wearable Insulin Pump Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Tubeless Wearable Insulin Pump Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Tubeless Wearable Insulin Pump by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tubeless Wearable Insulin Pump as of 2024)
 Table 16. Global Tubeless Wearable Insulin Pump Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Tubeless Wearable Insulin Pump Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Tubeless Wearable Insulin Pump Manufacturing Base and Headquarters
 Table 19. Global Tubeless Wearable Insulin Pump Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Tubeless Wearable Insulin Pump Sales by Type (2020-2025) & (K Units)
 Table 23. Global Tubeless Wearable Insulin Pump Sales by Type (2026-2031) & (K Units)
 Table 24. Global Tubeless Wearable Insulin Pump Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Tubeless Wearable Insulin Pump Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Tubeless Wearable Insulin Pump ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Tubeless Wearable Insulin Pump Sales by Application (2020-2025) & (K Units)
 Table 29. Global Tubeless Wearable Insulin Pump Sales by Application (2026-2031) & (K Units)
 Table 30. Tubeless Wearable Insulin Pump High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Tubeless Wearable Insulin Pump Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Tubeless Wearable Insulin Pump Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Tubeless Wearable Insulin Pump ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Tubeless Wearable Insulin Pump Growth Accelerators and Market Barriers
 Table 37. North America Tubeless Wearable Insulin Pump Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Tubeless Wearable Insulin Pump Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Tubeless Wearable Insulin Pump Growth Accelerators and Market Barriers
 Table 40. Europe Tubeless Wearable Insulin Pump Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Tubeless Wearable Insulin Pump Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Tubeless Wearable Insulin Pump Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Tubeless Wearable Insulin Pump Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Tubeless Wearable Insulin Pump Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Tubeless Wearable Insulin Pump Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Tubeless Wearable Insulin Pump Investment Opportunities and Key Challenges
 Table 47. Central and South America Tubeless Wearable Insulin Pump Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Tubeless Wearable Insulin Pump Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Tubeless Wearable Insulin Pump Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Insulet Corporation Corporation Information
 Table 51. Insulet Corporation Description and Major Businesses
 Table 52. Insulet Corporation Product Models, Descriptions and Specifications
 Table 53. Insulet Corporation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Insulet Corporation Sales Value Proportion by Product in 2024
 Table 55. Insulet Corporation Sales Value Proportion by Application in 2024
 Table 56. Insulet Corporation Sales Value Proportion by Geographic Area in 2024
 Table 57. Insulet Corporation Tubeless Wearable Insulin Pump SWOT Analysis
 Table 58. Insulet Corporation Recent Developments
 Table 59. Roche Corporation Information
 Table 60. Roche Description and Major Businesses
 Table 61. Roche Product Models, Descriptions and Specifications
 Table 62. Roche Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Roche Sales Value Proportion by Product in 2024
 Table 64. Roche Sales Value Proportion by Application in 2024
 Table 65. Roche Sales Value Proportion by Geographic Area in 2024
 Table 66. Roche Tubeless Wearable Insulin Pump SWOT Analysis
 Table 67. Roche Recent Developments
 Table 68. EOFlow Corporation Information
 Table 69. EOFlow Description and Major Businesses
 Table 70. EOFlow Product Models, Descriptions and Specifications
 Table 71. EOFlow Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. EOFlow Sales Value Proportion by Product in 2024
 Table 73. EOFlow Sales Value Proportion by Application in 2024
 Table 74. EOFlow Sales Value Proportion by Geographic Area in 2024
 Table 75. EOFlow Tubeless Wearable Insulin Pump SWOT Analysis
 Table 76. EOFlow Recent Developments
 Table 77. PharmaSens Corporation Information
 Table 78. PharmaSens Description and Major Businesses
 Table 79. PharmaSens Product Models, Descriptions and Specifications
 Table 80. PharmaSens Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. PharmaSens Sales Value Proportion by Product in 2024
 Table 82. PharmaSens Sales Value Proportion by Application in 2024
 Table 83. PharmaSens Sales Value Proportion by Geographic Area in 2024
 Table 84. PharmaSens Tubeless Wearable Insulin Pump SWOT Analysis
 Table 85. PharmaSens Recent Developments
 Table 86. CeQur Corporation Information
 Table 87. CeQur Description and Major Businesses
 Table 88. CeQur Product Models, Descriptions and Specifications
 Table 89. CeQur Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. CeQur Sales Value Proportion by Product in 2024
 Table 91. CeQur Sales Value Proportion by Application in 2024
 Table 92. CeQur Sales Value Proportion by Geographic Area in 2024
 Table 93. CeQur Tubeless Wearable Insulin Pump SWOT Analysis
 Table 94. CeQur Recent Developments
 Table 95. Debiotech Corporation Information
 Table 96. Debiotech Description and Major Businesses
 Table 97. Debiotech Product Models, Descriptions and Specifications
 Table 98. Debiotech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. Debiotech Recent Developments
 Table 100. Valeritas Corporation Information
 Table 101. Valeritas Description and Major Businesses
 Table 102. Valeritas Product Models, Descriptions and Specifications
 Table 103. Valeritas Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. Valeritas Recent Developments
 Table 105. Terumo Corporation Information
 Table 106. Terumo Description and Major Businesses
 Table 107. Terumo Product Models, Descriptions and Specifications
 Table 108. Terumo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. Terumo Recent Developments
 Table 110. MicroTech Medical Corporation Information
 Table 111. MicroTech Medical Description and Major Businesses
 Table 112. MicroTech Medical Product Models, Descriptions and Specifications
 Table 113. MicroTech Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 114. MicroTech Medical Recent Developments
 Table 115. Medtrum Technologies Corporation Information
 Table 116. Medtrum Technologies Description and Major Businesses
 Table 117. Medtrum Technologies Product Models, Descriptions and Specifications
 Table 118. Medtrum Technologies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 119. Medtrum Technologies Recent Developments
 Table 120. Key Raw Materials Distribution
 Table 121. Raw Materials Key Suppliers
 Table 122. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 123. Milestones in Production Technology Evolution
 Table 124. Distributors List
 Table 125. Market Trends and Market Evolution
 Table 126. Market Drivers and Opportunities
 Table 127. Market Challenges, Risks, and Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources


List of Figures
 Figure 1. Tubeless Wearable Insulin Pump Product Picture
 Figure 2. Global Tubeless Wearable Insulin Pump Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. All-throwable Product Picture
 Figure 4. Semi-throwable Product Picture
 Figure 5. Global Tubeless Wearable Insulin Pump Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Type 1 Diabetes
 Figure 7. Type 2 Diabetes
 Figure 8. Tubeless Wearable Insulin Pump Report Years Considered
 Figure 9. Global Tubeless Wearable Insulin Pump Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 10. Global Tubeless Wearable Insulin Pump Revenue (2020-2031) & (US$ Million)
 Figure 11. Global Tubeless Wearable Insulin Pump Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 12. Global Tubeless Wearable Insulin Pump Revenue Market Share by Region (2020-2031)
 Figure 13. Global Tubeless Wearable Insulin Pump Sales (2020-2031) & (K Units)
 Figure 14. Global Tubeless Wearable Insulin Pump Sales (CAGR) by Region (2020-2031) (K Units)
 Figure 15. Global Tubeless Wearable Insulin Pump Sales Market Share by Region (2020-2031)
 Figure 16. Top 5 and Top 10 Manufacturers Tubeless Wearable Insulin Pump Sales Volume Market Share in 2024
 Figure 17. Global Tubeless Wearable Insulin Pump Revenue Market Share Ranking (2024)
 Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 19. All-throwable Revenue Market Share by Manufacturer in 2024
 Figure 20. Semi-throwable Revenue Market Share by Manufacturer in 2024
 Figure 21. Global Tubeless Wearable Insulin Pump Sales Market Share by Type (2020-2031)
 Figure 22. Global Tubeless Wearable Insulin Pump Revenue Market Share by Type (2020-2031)
 Figure 23. Global Tubeless Wearable Insulin Pump Sales Market Share by Application (2020-2031)
 Figure 24. Global Tubeless Wearable Insulin Pump Revenue Market Share by Application (2020-2031)
 Figure 25. North America Tubeless Wearable Insulin Pump Sales YoY (2020-2031) & (K Units)
 Figure 26. North America Tubeless Wearable Insulin Pump Revenue YoY (2020-2031) & (US$ Million)
 Figure 27. North America Top 5 Manufacturers Tubeless Wearable Insulin Pump Sales Revenue (US$ Million) in 2024
 Figure 28. North America Tubeless Wearable Insulin Pump Sales Volume (K Units) by Type (2020- 2031)
 Figure 29. North America Tubeless Wearable Insulin Pump Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 30. North America Tubeless Wearable Insulin Pump Sales Volume (K Units) by Application (2020-2031)
 Figure 31. North America Tubeless Wearable Insulin Pump Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 32. US Tubeless Wearable Insulin Pump Revenue (2020-2031) & (US$ Million)
 Figure 33. Canada Tubeless Wearable Insulin Pump Revenue (2020-2031) & (US$ Million)
 Figure 34. Mexico Tubeless Wearable Insulin Pump Revenue (2020-2031) & (US$ Million)
 Figure 35. Europe Tubeless Wearable Insulin Pump Sales YoY (2020-2031) & (K Units)
 Figure 36. Europe Tubeless Wearable Insulin Pump Revenue YoY (2020-2031) & (US$ Million)
 Figure 37. Europe Top 5 Manufacturers Tubeless Wearable Insulin Pump Sales Revenue (US$ Million) in 2024
 Figure 38. Europe Tubeless Wearable Insulin Pump Sales Volume (K Units) by Type (2020-2031)
 Figure 39. Europe Tubeless Wearable Insulin Pump Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 40. Europe Tubeless Wearable Insulin Pump Sales Volume (K Units) by Application (2020-2031)
 Figure 41. Europe Tubeless Wearable Insulin Pump Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 42. Germany Tubeless Wearable Insulin Pump Revenue (2020-2031) & (US$ Million)
 Figure 43. France Tubeless Wearable Insulin Pump Revenue (2020-2031) & (US$ Million)
 Figure 44. U.K. Tubeless Wearable Insulin Pump Revenue (2020-2031) & (US$ Million)
 Figure 45. Italy Tubeless Wearable Insulin Pump Revenue (2020-2031) & (US$ Million)
 Figure 46. Russia Tubeless Wearable Insulin Pump Revenue (2020-2031) & (US$ Million)
 Figure 47. Asia-Pacific Tubeless Wearable Insulin Pump Sales YoY (2020-2031) & (K Units)
 Figure 48. Asia-Pacific Tubeless Wearable Insulin Pump Revenue YoY (2020-2031) & (US$ Million)
 Figure 49. Asia-Pacific Top 8 Manufacturers Tubeless Wearable Insulin Pump Sales Revenue (US$ Million) in 2024
 Figure 50. Asia-Pacific Tubeless Wearable Insulin Pump Sales Volume (K Units) by Type (2020- 2031)
 Figure 51. Asia-Pacific Tubeless Wearable Insulin Pump Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 52. Asia-Pacific Tubeless Wearable Insulin Pump Sales Volume (K Units) by Application (2020-2031)
 Figure 53. Asia-Pacific Tubeless Wearable Insulin Pump Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 54. Indonesia Tubeless Wearable Insulin Pump Revenue (2020-2031) & (US$ Million)
 Figure 55. Japan Tubeless Wearable Insulin Pump Revenue (2020-2031) & (US$ Million)
 Figure 56. South Korea Tubeless Wearable Insulin Pump Revenue (2020-2031) & (US$ Million)
 Figure 57. China Taiwan Tubeless Wearable Insulin Pump Revenue (2020-2031) & (US$ Million)
 Figure 58. India Tubeless Wearable Insulin Pump Revenue (2020-2031) & (US$ Million)
 Figure 59. Central and South America Tubeless Wearable Insulin Pump Sales YoY (2020-2031) & (K Units)
 Figure 60. Central and South America Tubeless Wearable Insulin Pump Revenue YoY (2020-2031) & (US$ Million)
 Figure 61. Central and South America Top 5 Manufacturers Tubeless Wearable Insulin Pump Sales Revenue (US$ Million) in 2024
 Figure 62. Central and South America Tubeless Wearable Insulin Pump Sales Volume (K Units) by Type (2021-2031)
 Figure 63. Central and South America Tubeless Wearable Insulin Pump Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 64. Central and South America Tubeless Wearable Insulin Pump Sales Volume (K Units) by Application (2020-2031)
 Figure 65. Central and South America Tubeless Wearable Insulin Pump Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 66. Brazil Tubeless Wearable Insulin Pump Revenue (2020-2025) & (US$ Million)
 Figure 67. Argentina Tubeless Wearable Insulin Pump Revenue (2020-2025) & (US$ Million)
 Figure 68. Middle East, and Africa Tubeless Wearable Insulin Pump Sales YoY (2020-2031) & (K Units)
 Figure 69. Middle East and Africa Tubeless Wearable Insulin Pump Revenue YoY (2020-2031) & (US$ Million)
 Figure 70. Middle East and Africa Top 5 Manufacturers Tubeless Wearable Insulin Pump Sales Revenue (US$ Million) in 2024
 Figure 71. Middle East and Africa Tubeless Wearable Insulin Pump Sales Volume (K Units) by Type (2021-2031)
 Figure 72. South America Tubeless Wearable Insulin Pump Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 73. Middle East and Africa Tubeless Wearable Insulin Pump Sales Volume (K Units) by Application (2020-2031)
 Figure 74. Middle East and Africa Tubeless Wearable Insulin Pump Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 75. GCC Countries Tubeless Wearable Insulin Pump Revenue (2020-2025) & (US$ Million)
 Figure 76. Turkey Tubeless Wearable Insulin Pump Revenue (2020-2025) & (US$ Million)
 Figure 77. Egypt Tubeless Wearable Insulin Pump Revenue (2020-2025) & (US$ Million)
 Figure 78. South Africa Tubeless Wearable Insulin Pump Revenue (2020-2025) & (US$ Million)
 Figure 79. Tubeless Wearable Insulin Pump Industry Chain Mapping
 Figure 80. Regional Tubeless Wearable Insulin Pump Manufacturing Base Distribution (%)
 Figure 81. Global Tubeless Wearable Insulin Pump Production Market Share by Region (2020-2031)
 Figure 82. Tubeless Wearable Insulin Pump Production Process
 Figure 83. Regional Tubeless Wearable Insulin Pump Production Cost Structure
 Figure 84. Channels of Distribution (Direct Vs Distribution)
 Figure 85. Bottom-up and Top-down Approaches for This Report
 Figure 86. Data Triangulation
 Figure 87. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture